BioStem Technologies gets up to $40M committed equity facility
BioStem Technologies said it entered a committed equity facility for up to $40 million.
, Sept. 18, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. NASDAQ:BSEM (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced it has entere…